OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Penson on Ongoing Research in Prostate Cancer

May 14th 2020

David F. Penson, MD, MPH, MMHC, discusses ongoing research in prostate cancer.

Dr. Dahut on the Future of Genetic Screening in Prostate Cancer

May 14th 2020

William L. Dahut, MD, discusses the future of genetic screening in prostate cancer.

The Rationale for Investigating DNA-PK as a Target in Prostate Cancer

May 14th 2020

Karen E. Knudsen, PhD, discusses the rationale for investigating DNA-dependent protein kinase as a target in prostate cancer.

Dr. Huh on SGO COVID-19 Task Force Efforts

May 14th 2020

Warner K. Huh, MD, discusses some of the key challenges faced in the management of gynecologic cancers in light of the COVID-19 crisis, shares some of the resources provided by the SGO COVID-19 task force, and projects what is needed to quell the pandemic, which he refers to as version of the Great Depression.

Dr. Bose on Novel Agents Under Investigation in Myelofibrosis

May 14th 2020

Prithviraj Bose, MD, discusses novel agents under investigation in myelofibrosis.

Dr. Iyer on TRAEs With Erdafitinib in Urothelial Cancer

May 14th 2020

Gopa Iyer, MD, discusses treatment-related adverse events (TRAEs) with erdafitinib (Balversa) in urothelial cancer.

Dr. Pagel on the Implications of Polatuzumab Vedotin Approval in DLBCL

May 14th 2020

John M. Pagel, MD, PhD, discusses the implications of the FDA approval of polatuzumab vedotin in diffuse large B-cell lymphoma.

Dr. Wang on the Evolution of Treatment in MCL

May 14th 2020

Michael Wang, MD, discusses the evolution of treatment in mantle cell lymphoma.

Dr. Smith on Frontline Treatment Options in MCL

May 14th 2020

Sonali M. Smith, MD, discusses frontline treatment options in mantle cell lymphoma.

Dr. Rugo on Takeaways From the IMpassion130 Trial in TNBC

May 14th 2020

Hope S. Rugo, MD, discusses takeaways from the phase 3 IMpassion130 trial in metastatic triple-negative breast cancer.

Challenges of Implementing Alternative Delivery Models for Genetic Counseling in Prostate Cancer

May 14th 2020

Alanna K. Rahm, PhD, MS, discusses the challenges of implementing alternate delivery models for genetic counseling in prostate cancer.

Dr. Iyer on TRAEs With Erdafitinib in Urothelial Cancer

May 14th 2020

Gopa Iyer, MD, discusses treatment-related adverse events (TRAEs) with erdafitinib (Balversa) in urothelial cancer.

Dr. Bose on Novel Agents Under Investigation in Myelofibrosis

May 14th 2020

Prithviraj Bose, MD, discusses novel agents under investigation in myelofibrosis.

Dr. Branagan on the Results of the TOURMALINE-MM3 Trial in Multiple Myeloma

May 14th 2020

Andrew Branagan, MD, discusses the results of the phase 3 TOURMALINE-MM3 trial in multiple myeloma.

Dr. Pagel on the Implications of Polatuzumab Vedotin Approval in DLBCL

May 13th 2020

John M. Pagel, MD, PhD, discusses the implications of the FDA approval of polatuzumab vedotin in diffuse large B-cell lymphoma.

Challenges of Implementing Alternative Delivery Models for Genetic Counseling in Prostate Cancer

May 13th 2020

Alanna K. Rahm, PhD, MS, discusses the challenges of implementing alternative delivery models for genetic counseling in prostate cancer.

Dr. Smith on Frontline Treatment Options in MCL

May 13th 2020

Sonali M. Smith, MD, discusses frontline treatment options in mantle cell lymphoma.

Dr. Rugo on Takeaways From the IMpassion130 Trial in TNBC

May 13th 2020

Hope S. Rugo, MD, discusses takeaways from the phase 3 IMpassion130 trial in metastatic triple-negative breast cancer.

Dr. Gayle on Current Treatment Options in Breast Implant-Associated ALCL

May 13th 2020

Lloyd B. Gayle, MD, discusses current treatment options for patients who develop breast implant–associated anaplastic large cell lymphoma (ALCL).

Dr. Niu on Combining Immunotherapy With VEGF Inhibitors in ES-SCLC

May 13th 2020

Jiaxin (Jason) Niu, MD, PhD, discusses combining immunotherapy with VEGF Inhibitors in extensive-stage small cell lung cancer.